 | This article may be too technical for most readers to understand. (September 2023) |
| Rhinitis medicamentosa | |
|---|---|
| Other names | Rebound congestion |
 | |
| Specialty | Otorhinolaryngology |
| Symptoms | Nasal congestion |
| Usual onset | After 5–7 days of use of topical decongestant nasal sprays |
| Causes | Overuse of decongestant nasal sprays and certain oral medications |
| Prevention | Limiting use of decongestant nasal sprays and other potentially problematic medications |
| Treatment | Ceasing use of offending medications |
Rhinitis medicamentosa (or RM, also known as rebound congestion) is a condition of rebound nasal congestion suspected to be brought on by extended use of topical decongestants (e.g., oxymetazoline, phenylephrine, xylometazoline, and naphazoline nasal sprays) and certain oral medications (e.g., sympathomimetic amines and various 2-imidazolines) that constrict blood vessels in the lining of the nose, although evidence has been contradictory.[1]
- ^ Mortuaire, G.; de Gabory, L.; François, M.; Massé, G.; Bloch, F.; Brion, N.; Jankowski, R.; Serrano, E. (June 2013). "Rebound congestion and rhinitis medicamentosa: Nasal decongestants in clinical practice. Critical review of the literature by a medical panel". European Annals of Otorhinolaryngology, Head and Neck Diseases. 130 (3): 137–144. doi:10.1016/j.anorl.2012.09.005. PMID 23375990.